Nasdaq:OMER
OMEROS CORP
A capital-intensive technology enterprise with massive marketable securities holdings and significant negative operating cash flow driven by heavy R&D spending.
Key Metrics
Investment Thesis
Bull Case
Investors may view the stock as a deep-value opportunity given the massive cash proceeds from marketable securities sales ($1.07B) and high paid-in capital, suggesting potential for a strategic turnaround or asset monetization. The significant R&D investment of $119.5M could imply a hidden product pipeline waiting to be commercialized once current structural issues are resolved.
Bear Case
The stock is highly speculative due to the absence of reported revenue and gross profit, coupled with a retained earnings deficit of -$910.3M that indicates long-term viability issues. With total liabilities of $459.7M significantly outweighing equity, the company faces an elevated risk of dilution or insolvency without a clear path to positive cash conversion.
About OMEROS CORP
OMEROS CORP (OMER) is a technology-focused enterprise operating with significant capital deployment in marketable securities, serving markets where it leverages substantial research and development investments to generate future value. The company reports complex financial structures involving large accrued expenses and long-term liabilities, indicative of a growth-stage or distressed entity strategy rather than traditional revenue-generating operations. Its business model appears centered on asset management or restructuring activities given the absence of reported cost of revenue and gross profit in the latest annual data.
Analysis
Management Discussion
The company experienced a sharp deterioration in financial health, with net profit dropping from a positive $47.4M in 2022 to a massive loss of $156.8M in 2024. Operating cash flow turned negative at -$148.8M despite generating $62.9M from financing and substantial investing inflows, indicating reliance on capital markets rather than organic operations. The balance sheet shows a critical deficit with shareholders' equity of -$182.6M against total assets of $277.1M, highlighting severe solvency concerns.
Industry Overview
The sector typically involves high capital expenditure and R&D intensity where companies often operate with negative operating cash flow during early development phases before monetization. Companies in this space frequently utilize significant marketable securities as liquidity bridges while navigating regulatory hurdles and market entry barriers.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| Cost of Revenue | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 |
| Operating Expenses | $163.4M | $164.5M | $169.3M |
| Operating Income | $-163.4M | $-164.5M | $-169.3M |
| R&D | $112.7M | $114.9M | $119.5M |
| G&A | $50.7M | $49.7M | $49.7M |
| Stock-Based Comp | $14.1M | $11.7M | $10.5M |
| D&A | $952.0K | $920.0K | $950.0K |
| Other OpEx | $0 | $0 | $0 |
| Non-Operating Income | $-18.6M | $-10.4M | $-11.1M |
| Interest Expense | $22.7M | $30.8M | — |
| Interest Income | — | $14.7M | $8.4M |
| Pre-Tax Income | $-182.0M | $-174.9M | $-180.3M |
| Income Tax | $0 | $0 | $2.3M |
| Continuing Ops | $-182.0M | $-174.9M | $-182.6M |
| Discontinued Ops | $229.4M | $57.1M | $25.8M |
| Net Income | $47.4M | $-117.8M | $-156.8M |
| Minority Interest | $0 | $0 | $0 |
| Net to Common | $47.4M | $-117.8M | $-156.8M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Current Assets | $443.2M | $217.9M | $134.1M |
| Cash & Equivalents | $11.0M | $7.1M | $3.4M |
| Marketable Securities | $183.9M | $164.7M | $86.7M |
| Prepaid Expenses | $6.3M | $8.6M | $7.2M |
| Other Current Assets | $242.0M | $37.5M | $36.8M |
| Long-Term Assets | $147.7M | $160.4M | $143.0M |
| PP&E (Net) | — | $1.9M | $2.7M |
| Operating Leases | $21.8M | $18.6M | $15.0M |
| Other LT Assets | $126.0M | $139.8M | $125.3M |
| Total Assets | $591.0M | $378.3M | $277.1M |
| Current Liabilities | $136.4M | $53.3M | $79.5M |
| Accounts Payable | $6.0M | $7.7M | $5.9M |
| Current Leases | $3.9M | — | $5.2M |
| Taxes Payable | $4.9M | $316.0K | — |
| Other Current Liab | $91.1M | $13.4M | $42.4M |
| Long-Term Liabilities | $368.9M | $349.9M | $380.2M |
| LT Operating Leases | $22.0M | — | $12.2M |
| Other LT Liab | $346.9M | — | $367.9M |
| Total Liabilities | $505.3M | $403.3M | $459.7M |
| Shareholders' Equity | $85.7M | $-25.0M | $-182.6M |
| Paid-In Capital | — | — | $727.2M |
| Retained Earnings | $-635.7M | $-753.5M | $-910.3M |
| Total L&E | $591.0M | $378.3M | $277.1M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net Income (CFO) | $47.4M | $-117.8M | $-156.8M |
| Non-Cash Adjustments | $-297.0M | $390.0M | $19.7M |
| Working Capital Changes | $163.1M | $-197.5M | $-11.7M |
| Cash from Operations | $-86.5M | $74.7M | $-148.8M |
| Capital Expenditures | $113.0K | $426.0K | $165.0K |
| Cash from Investing | $-127.6M | $27.5M | $82.2M |
| Share Buybacks | — | $4.7M | $11.9M |
| Cash from Financing | $124.2M | $-106.1M | $62.9M |
| FX Effect | $0 | $0 | $0 |
| Net Change in Cash | $-89.8M | $-3.9M | $-3.7M |
| Beginning Cash | $100.8M | $11.0M | $7.1M |
| Ending Cash | $11.0M | $7.1M | $3.4M |
Frequently Asked Questions
How does OMEROS CORP make money?
Research and Development Operations, Marketable Securities Management, and Asset Restructuring Services
What are the main risks for OMER?
Severe operating losses with a net profit deficit of $156.8M in 2024, declining profitability trajectory from $47.4M in 2022 to negative levels, significant debt burden with total liabilities exceeding $459M, and lack of revenue generation or cost of revenue reporting.
What is OMER's competitive advantage?
Substantial liquidity buffer provided by $86.7M in marketable securities, high paid-in capital base of $727.2M suggesting strong institutional backing, and aggressive investment capacity evidenced by $82.2M cash flow from investing.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.